Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Withdrawn
×
Inotuzumab Ozogamicin
×
Clear all
Filters
3
NCT03628053
2020-07-09
OBERON
Novartis
Phase 3
Withdrawn